SANTEN PHARMACEUTICAL CO.,LTD. Logo

SANTEN PHARMACEUTICAL CO.,LTD.

A global company specializing in pharmaceuticals and medical devices for ophthalmology.

4536 | T

Overview

Corporate Details

ISIN(s):
JP3336000009
LEI:
Country:
Japan
Address:
大阪市北区大深町4番20号

Description

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 06:37
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.5 KB
2025-11-14 01:56
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-11-10 07:02
確認書
Japanese ZIP 8.7 KB
2025-11-10 07:01
半期報告書-第114期(2025/04/01-2026/03/31)
Japanese ZIP 366.6 KB
2025-10-15 03:28
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.2 KB
2025-09-12 04:58
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-08-13 03:24
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.8 KB
2025-07-15 04:38
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.2 KB
2025-06-25 04:08
臨時報告書
Japanese ZIP 26.5 KB
2025-06-24 09:22
臨時報告書
Japanese ZIP 32.1 KB
2025-06-23 08:29
内部統制報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 24.3 KB
2025-06-23 08:28
確認書
Japanese ZIP 8.5 KB
2025-06-23 08:27
有価証券報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 2.2 MB
2025-06-13 04:35
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 22.1 KB
2025-04-15 06:53
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 21.3 KB

Automate Your Workflow. Get a real-time feed of all SANTEN PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANTEN PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANTEN PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.